Asian Phytoceuticals PCL
SET:APCO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.82
8.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches THB.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Asian Phytoceuticals PCL
Other Current Liabilities
Asian Phytoceuticals PCL
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Asian Phytoceuticals PCL
SET:APCO
|
Other Current Liabilities
฿11.1m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-7%
|
|
|
D
|
Do Day Dream PCL
SET:DDD
|
Other Current Liabilities
฿16.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
T
|
Thai Nippon Rubber Industry PCL
SET:TNR
|
Other Current Liabilities
฿102.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
I
|
Inter Pharma PCL
SET:IP
|
Other Current Liabilities
฿91.5m
|
CAGR 3-Years
13%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
K
|
Karmarts PCL
SET:KAMART
|
Other Current Liabilities
฿140.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
D
|
DOD Biotech PCL
SET:DOD
|
Other Current Liabilities
฿154.2m
|
CAGR 3-Years
36%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Asian Phytoceuticals PCL
Glance View
Asian Phytoceuticals Public Co., Ltd. engages in the research and development, manufacture, and distribution of health and beauty products from natural extracts. The company is headquartered in Lamphun, Lamphun. The company went IPO on 2011-11-04. The firm specializes in the manufacture of dietary supplements, cosmetics and personal care products developed from natural plant and botanical extracts. The firm offers products across various categories, including anti-wrinkle products, slimming products, and other health products. The Company’s slimming products are sold under Gold Shape brand. The firm's anti-wrinkle and anti-spots products are sold under brands, including Gold Figor, Garcinia and Asian Life. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
See Also
What is Asian Phytoceuticals PCL's Other Current Liabilities?
Other Current Liabilities
11.1m
THB
Based on the financial report for Jun 30, 2024, Asian Phytoceuticals PCL's Other Current Liabilities amounts to 11.1m THB.
What is Asian Phytoceuticals PCL's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-7%
Over the last year, the Other Current Liabilities growth was -50%. The average annual Other Current Liabilities growth rates for Asian Phytoceuticals PCL have been -3% over the past three years , and -7% over the past ten years .
You don't have any saved screeners yet
